Marketable Securities

6 Months Ended

Jun. 30, 2021

Marketable Securities

Note 4. Marketable Securities

(4) Marketable Securities

The following table is a summary of marketable securities at June 30, 2021:

	Amortized		Gross realized		Gross unrealized			Estimated
	Cost		Gain		Loss			Fair Value
Equities		958,296		6,994		(5,822	)		959,468
Fixed Income		100,950		10					100,960
Other		49,720				(510	)		49,210
Total Securities	$	1,108,966	$	7,004	$	(6,332	)	$	1,109,638

Cash and cash equivalents at June 30, 2021 was $3,888,974.

The disclosed instruments above are considered a level 1 instrument.

When evaluating an investment for impairment, the Company reviews factors including the length of time and extent to which fair value has been below cost basis, the financial condition of the issuer, changes in market interest rates and whether it is more likely than not the Company will be required to sell the investment before recovery of the investment’s cost basis. As of June 30, 2021, the Company does not consider any of its investments to be impaired.